Biotech Short Candidates Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (657)	5/20/2004 8:25:47 PM
From: Miljenko Zuanic	of 897

">>10:33AM Onyx Pharma target raised to $66 from $40 at JMP (ONXX) 56.12 +0.83: JMP Securities maintains their Outperform on ONXX and raises their target to $66 from $40 following stronger than expected Q1 results; while the stock's valuation is hardly a bargain, firm believes that it is not out of line with other biotech co's with high-quality products in pivotal trials and near registration; firm views ONXX's lead compound BAY 43-9006 as one of the most exciting compounds in the collective pipeline of the biotech and pharma industries, and believes that the stock can continue to move upward as long as clinical data are good.<<" What are the bad news?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next